A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX&unknown; in healthy children

Author： Lau Y.-L.   Vessey S.J.R.   Chan I.S.F.   Lee T.-L.   Huang L.-M.   Lee C.-Y.   Lin T.-Y.   Lee B.W.   Kwan K.   Kasim S.M.   Chan C.Y.   Kaplan K.M.   Distefano D.J.   Harmon A.L.   Golie A.   Hartzel J.   Xu J.   Li S.   Matthews H.   Sadoff J.C.   Shaw A.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.23, 2002-07, pp. : 2942-2949

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax(R)) in healthy adolescents and adults

By Oka/Merck Varicella Vaccine Study Group   Kuter B.J.   Ngai A.   Patterson C.M.   Staehle B.O.   Cho I.   Matthews H.   Provost P.J.   White C.J.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 967-972

Elsevier

Access to resources Recommend Favorite

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax(R)) in children and adults

By Krah D.L.   Cho I.   Schofield T.   Ellis R.W.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity of a combined high dose hepatitis A and hepatitis B vaccine, compared to that of Twinrix&unknown; in healthy Indian children

By Guptan R.C.   Thakur V.   Safary A.   Sarin S.K.  

Vaccine, Vol. 20, Iss. 16, 2002-05 ,pp. : 2102-2106

Elsevier

Access to resources Recommend Favorite

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

By Rothstein E.P.   Anderson E.L.   Decker M.D.   Poland G.A.   Reisinger K.S.   Blatter M.M.   Jacobson R.M.   Mink C.M.   Gennevois D.   Izu A.E.   Sinangil F.   Langenberg A.G.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2999-3006

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

By Hoan-Jong L.   Jin-Han K.   Henrichsen J.   Konradsen H.B.   Seong-Hee J.   Hee-Young S.   Hyo-Seop A.   Yong C.   Hessel L.   Sung-Woo N.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1533-1538

Elsevier

Access to resources Recommend Favorite